Clinical Trial Update: Tiotropium in Patients With Tuberculosis (TB) Destroyed Lung

View source ↗

Summary

A clinical trial update evaluating tiotropium for patients with destroyed lung due to tuberculosis, investigating potential lung function benefits.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Tuberculosis

Drugs mentioned

• tiotropium (tiotropium)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Lung Disease, Obstructive, Tuberculosis | Status: UNKNOWN